Lysosomal proteome characterization during TRPML1 activation by MLSA5 in human cancer cells
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
To capture the changes in the lysosomal proteome upon TRPML1 activation, achieved using a small molecule agonist MLSA5, human cancer cells, with or without gene-editing, stably expressing TMEM192-mRFP-3xHA (Lyso-IP), were treated with MLSA5 and Lyso-IP samples were prepared and processed for TMT-MS analysis. Each condition was performed in triplicate.
创建时间：
2025-04-22
